HPK1-IN-32
4-[5-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-yl]-N-[2-[(3R)-3-fluoropyrrolidin-1-yl]ethyl]-2,6-dimethylbenzamide
Molecular Identity
HPK1-IN-32
4-[5-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-yl]-N-[2-[(3R)-3-fluoropyrrolidin-1-yl]ethyl]-2,6-dimethylbenzamide
PubChem CID: 164889473
2D Structure
Properties
C28H37FN8O2
Molecular Formula
536.60
Molecular Weight
g/mol
536.3024
Exact Mass
Da
2.4
XLogP
Drug-like (Lipinski: < 5)
114
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
790
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(19)
HPK1-IN-322766481-17-6BGB 15025BGB-15025(R)-4-(5-Amino-6-((1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)oxy)pyrazin-2-yl)-N-(2-(3-fluoropyrrolidin-1-yl)ethyl)-2,6-dimethylbenzamideorb1818818SCHEMBL24269852BDBM698040EX-A6852AT42683US20240317714, Example A34(R)-4-[5-Amino-6-[[1-(1-methyl-4-piperidyl)-4-pyrazolyl]oxy]-2-pyrazinyl]-N-[2-(3-fluoro-1-pyrrolidinyl)ethyl]-2,6-dimethylbenzamideDA-64261MS-29913SY343386
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to HPK1-IN-32
Loading drug network...